InvestorsHub Logo
Followers 21
Posts 4211
Boards Moderated 0
Alias Born 05/10/2012

Re: None

Tuesday, 11/28/2017 1:51:52 PM

Tuesday, November 28, 2017 1:51:52 PM

Post# of 144814
So this statement comes from the Chairman of Austrianova...and this is why he wanted to renegotiated the deal with pmcb...he knows what's coming....


We are pleased to be working with Eurofins, who has been both professional and interactive, during this process leading up to what will be the creation of PharmaCyte’s Master Cell Bank of the cells that make up the Cell-in-a-Box® encapsulated cell product for the treatment of pancreatic cancer. This step certainly clears the way to produce the MCB,” stated Prof. Walter H. Günzburg, Chairman of the Board and Chief Development Officer of Austrianova and PharmaCyte’s Chief Scientific Officer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News